在患有玻璃眼或眼睛高血压的患者中,Omidenepag Isopropyl 与 Timolol 相比:两项随机的第三期试验 (SPECTRUM 4 和 3)
Jason Bacharach1, Jacob W Brubaker2, David G Evans3
1From the North Bay Eye Associates (J.B.), Petaluma, California, USA.
American journal of ophthalmology
|February 23, 2024
概括
在降低青光眼患者的眼内压力 (IOP) 方面,Omidenepag isopropyl (OMDI) 证明与蒂莫洛尔无劣. OMDI显示出一致的疗效和有利的安全性,这表明潜在的长期益处.
科学领域:
- 眼科医生 眼科 眼科
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 玻璃眼和眼睛高血压 (OHT) 是导致视力丧失的主要原因.
- 有效降低眼内压力 (IOP) 对于管理这些情况至关重要.
- 蒂莫洛尔是一种常见的第一线治疗方法,但需要替代方案.
研究的目的:
- 为了评估omidenepag isopropyl (OMDI) 0.002%的有效性和安全性,与 timolol 0.5%相比,用于降低IOP.
- 为了确定OMDI在患有青光瘤或OHT的成年患者中与蒂莫洛尔的非劣等性.
- 评估OMDI在儿童和成人患者的长期疗效和安全性.
主要方法:
- 第三阶段,随机,双面罩,受控,非劣等性研究 (SPECTRUM 4和3).
- 包括成年患者 (N=409在SPECTRUM 4,N=413在SPECTRUM 3) 和儿科患者 (N=13在SPECTRUM 3) 患有青光眼或OHT.
- 主要终点:在3个月内减少IOP;次要:对不良事件 (AE) 的安全评估.
主要成果:
- 在SPECTRUM 4的IOP降低方面,OMDI实现了与蒂莫洛尔的非劣势性.
- 在所有研究中,OMDI的IOP降低范围一致 (-5.6至-5.9毫米升).
- 与蒂莫洛尔相比,OMDI具有更多的眼部副作用,但与蒂莫洛尔相比,改变外观的副作用较少;没有发现新的安全问题. 在长期使用OMDI的伪发性患者中观察到黄斑.
结论:
- SPECTRUM 4 和 3 证实了OMDI与提摩洛尔相比3个月的IOP降低效果和安全性.
- 来自SPECTRUM 3的12个月数据表明,OMDI对玻璃眼和OHT患者的潜在长期益处.
- OMDI代表了一种可行的替代方案,用于玻璃眼和OHT的IOP管理.
相关概念视频
Open Angle Glaucoma: Treatment
449
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
449
Angle Closure Glaucoma: Treatment
498
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
498
Glaucoma: Overview
570
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
570
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


